UnitedHealth Group Incorporated (NYSE:UNH) Given Average Rating of “Moderate Buy” by Analysts

UnitedHealth Group Incorporated (NYSE:UNHGet Free Report) has received a consensus rating of “Moderate Buy” from the eighteen brokerages that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation, fourteen have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $579.33.

Several research analysts have recently weighed in on UNH shares. Stephens reiterated an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Royal Bank of Canada reiterated an “outperform” rating and set a $596.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 29th. Barclays initiated coverage on shares of UnitedHealth Group in a research note on Wednesday, March 6th. They set an “overweight” rating and a $551.00 price target on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Friday, January 19th. Finally, Bank of America restated a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th.

Read Our Latest Analysis on UNH

UnitedHealth Group Trading Up 0.3 %

Shares of UNH stock opened at $494.70 on Monday. UnitedHealth Group has a 12-month low of $445.68 and a 12-month high of $554.70. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. The firm’s 50 day moving average is $502.51 and its 200 day moving average is $518.82. The stock has a market capitalization of $456.08 billion, a P/E ratio of 20.75, a P/E/G ratio of 1.35 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $94.43 billion for the quarter, compared to analysts’ expectations of $92.13 billion. During the same quarter last year, the company posted $5.34 earnings per share. The firm’s quarterly revenue was up 14.1% on a year-over-year basis. Research analysts expect that UnitedHealth Group will post 27.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 31.54%.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On UnitedHealth Group

Several large investors have recently added to or reduced their stakes in UNH. Kapitalo Investimentos Ltda lifted its position in shares of UnitedHealth Group by 336.5% in the 4th quarter. Kapitalo Investimentos Ltda now owns 1,100 shares of the healthcare conglomerate’s stock worth $579,000 after purchasing an additional 848 shares during the period. Newbridge Financial Services Group Inc. lifted its position in shares of UnitedHealth Group by 17.3% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 1,134 shares of the healthcare conglomerate’s stock worth $597,000 after purchasing an additional 167 shares during the period. HighPoint Advisor Group LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $10,386,000. Fairman Group LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $198,000. Finally, Grayhawk Investment Strategies Inc. lifted its position in shares of UnitedHealth Group by 84.0% in the 4th quarter. Grayhawk Investment Strategies Inc. now owns 173 shares of the healthcare conglomerate’s stock worth $91,000 after purchasing an additional 79 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

(Get Free Report

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.